Uncovering Tumorigenesis Circuitry with Combinatorial CRISPR.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34911780.
- Also identified by DOI 10.1158/0008-5472.CAN-21-3672.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oncogenesis relies on the alteration of multiple driver genes, but precisely which groups of alterations lead to cancer is not well understood. To chart these combinations, Zhao and colleagues use the CRISPR-Cas9 system to knockout all pairwise combinations among 52 tumor suppressor genes, with the goal of identifying groups of alterations that collaborate to promote cell growth. Interaction screens are performed across multiple models of tumorigenesis in cell cultures and mice, revealing clear cooperation among <i>NF2</i>, <i>PTEN</i>, and <i>TP53</i> in multiple models. These and other strongly synergistic interactions are characterized further by single-cell transcriptomic profiling. This methodology presents a scalable approach to move beyond single-gene drivers to map the complex gene networks that give rise to tumorigenesis.<i>See related article by Zhao et al., p. 6090</i>.
Medical subject headings
- CRISPR-Cas Systems
- Carcinogenesis